On April 13, Needham maintained its $14 target price for the stock, implying upside potential of more than 148%.

SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, and Olink Holding AB (publ)(“Olink”)(Nasdaq: OLK), a ...

As drug discovery demands greater speed and accuracy, advances in automation are transforming high-throughput screening. Rob ...

SPT Labtech Ltd. recently partnered with Alithea Genomics SA to integrate its firefly liquid handling platform with Alithea’s single-cell RNA-sequency technology to create a scalable and reproducible ...